taro-perampanel tablet
taro pharmaceuticals inc - perampanel - tablet - 2mg - perampanel 2mg
taro-perampanel tablet
taro pharmaceuticals inc - perampanel - tablet - 4mg - perampanel 4mg
taro-perampanel tablet
taro pharmaceuticals inc - perampanel - tablet - 6mg - perampanel 6mg
taro-perampanel tablet
taro pharmaceuticals inc - perampanel - tablet - 8mg - perampanel 8mg
taro-perampanel tablet
taro pharmaceuticals inc - perampanel - tablet - 10mg - perampanel 10mg
taro-perampanel tablet
taro pharmaceuticals inc - perampanel - tablet - 12mg - perampanel 12mg
fycompa- perampanel tablet fycompa- perampanel suspension
eisai inc. - perampanel (unii: h821664npk) (perampanel - unii:h821664npk) - perampanel 2 mg - fycompa is indicated for the treatment of partial-onset seizures with or without secondarily generalized seizures in patients with epilepsy 4 years of age and older. fycompa is indicated as adjunctive therapy for the treatment of primary generalized tonic-clonic seizures in patients with epilepsy 12 years of age and older. none. pregnancy exposure registry there is a pregnancy exposure registry that monitors pregnancy outcomes in women exposed to antiepileptic drugs (aeds), such as fycompa, during pregnancy. encourage women who are taking fycompa during pregnancy to enroll in the north american antiepileptic drug (naaed) pregnancy registry by calling 1-888-233-2334 or visiting http://www.aedpregnancyregistry.org. risk summary there are no adequate data on the developmental risk associated with use in pregnant women. in animal studies, perampanel induced developmental toxicity in pregnant rat and rabbit at clinically relevant doses [ see data ] . in the u.s. general population the estimated background risk
fycompa 2 mg film coated tablets
eisai israel ltd., israel - perampanel as anhydrous - film coated tablets - perampanel as anhydrous 2 mg - perampanel - perampanel - fycompa is indicated for the adjunctive treatment of partial-onset seizures with or without secondarily generalised seizures in patients with epilepsy aged 4 years and older.fycompa is indicated for the adjunctive treatment of primary generalized tonic-clonic seizures in patients with epilepsy aged 12 years and older with idiopathic generalised epilepsy..
fycompa 4 mg film coated tablets
eisai israel ltd., israel - perampanel as anhydrous - film coated tablets - perampanel as anhydrous 4 mg - perampanel - perampanel - fycompa is indicated for the adjunctive treatment of partial-onset seizures with or without secondarily generalised seizures in patients with epilepsy aged 4 years and older.fycompa is indicated for the adjunctive treatment of primary generalized tonic-clonic seizures in patients with epilepsy aged 12 years and older with idiopathic generalised epilepsy..
fycompa 6 mg film coated tablets
eisai israel ltd., israel - perampanel as anhydrous - film coated tablets - perampanel as anhydrous 6 mg - perampanel - perampanel - fycompa is indicated for the adjunctive treatment of partial-onset seizures with or without secondarily generalised seizures in patients with epilepsy aged 4 years and older.fycompa is indicated for the adjunctive treatment of primary generalized tonic-clonic seizures in patients with epilepsy aged 12 years and older with idiopathic generalised epilepsy..